Thiogenesis Therapeutics, Inc.

Quick facts

Phase 2 pipeline

• D-Mannitol · Neurology
  D-Mannitol is an osmotic agent that draws fluid into the intracellular space to reduce intracranial pressure and improve cellular hydration.
• TTI-0102: cysteamine-pantetheine disulfide

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Thiogenesis Therapeutics, Inc. portfolio CI brief
• Thiogenesis Therapeutics, Inc. pipeline updates RSS